To date, standard recommendations for the management of stress urinary incontinence (SUI) would be either pelvic floor muscle training (PFMT) or surgery. A new form of drug treatment with a serotonin-noradrenaline reuptake inhibitor (SNRI), duloxetine, may now have a place in treatment of this condition.
Mariappan, P., Ballantyne, Z., N'Dow, J. M. O., & Alhasso, A. A. (2005). Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Cochrane Database of Systematic Reviews, (3), CD004742. https://doi.org/10.1002/14651858.CD004742.pub2